Revision (Tables)

12 Months Ended

Dec. 31, 2019

Equity [Abstract]

Schedule of revision of accumulated other comprehensive income

	As Reported			As Revised
Accumulated deficit	$	(23,913,011	)	$	(25,431,084	)
Accumulated other comprehensive loss - foreign currency translation adjustment	$	(302,023	)	$	(297,571	)
Total Avalon GloboCare Corp. stockholders' equity and non-controlling interest	$	7,260,433		$	5,746,812
Non-controlling interest	$	(1,513,621	)	$	-

The Company's condensed consolidated statement of operations for the three and nine months ended September 30, 2019 have been restated for the impact of this adjustment as follows:

	As Reported						As Revised
	Three Months Ended			Nine Months Ended			Three Months Ended			Nine Months Ended
	September 30, 2019			September 30, 2019			September 30, 2019			September 30, 2019
Loss from noncontrolling interest deficit adjustment	$			$			$	(1,042,210	)	$	(862,200	)
Total Other Income (Expense), net	$	1,142,289		$	1,007,602		$	100,079		$	145,402
LOSS BEFORE INCOME TAXES	$	(4,334,058	)	$	(13,277,810	)	$	(5,376,268	)	$	(14,140,010	)
NET LOSS	$	(4,334,058	)	$	(13,277,810	)	$	(5,376,268	)	$	(14,140,010	)
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST	$	(475,863	)	$	(656,575	)	$	-		$	-
NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS	$	(3,858,195	)	$	(12,621,235	)	$	(5,376,268	)	$	(14,140,010	)
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS:
Basic and diluted	$	(0.05	)	$	(0.17	)	$	(0.07	)	$	(0.19	)

The Company's condensed consolidated statement of cash flow for the nine months ended September 30, 2019 have been restated for the impact of this adjustment as follows:

	As Reported			As Revised
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(13,277,810	)	$	(14,140,010	)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss from noncontrolling interest deficit adjustment	$	-		$	862,200